NOXO Anti-Anxiety Balm From Adoodle Reduces Anxiety Associated With Panic Attacks, Shortness Of Breath, Dizziness, Hot Flashes And/Or Chills. - Available In September

Wynnewood, PA - (WORLD STOCK WIRE) - June 30, 2009 -- Adoodle, Inc, (OTC Pink Sheets: ADDE) announced today that NOXO Anti-Anxiety balm would be available in September at a price of $ 1 per dose at retail stores and the Internet.

According to a study at Tubingen University in Germany, when the ingredients in NOXO Anti-Anxiety balm were applied topically, under the nostrils, they reduced the startle reaction, also called the startle response, startle reflex or alarm reaction, which is the response of mind and body to a sudden unexpected stimulus, such as a flash of light, or a loud noise. This study showed that the NOXO Anti-Anxiety formulation has calming effects due to the essential properties of its ingredients. Medical experiments have also shown that the NOXO Anti-Anxiety formulation reduces stress and anxiety in cancer patients undergoing Magnetic Resonance Imaging – a diagnostic procedure known to be stressful. It was reported that a massive 63% less anxiety occurred when the NOXO Anti-Anxiety formulation was applied topically during the procedure.

NOXO Anti-Anxiety balm, a proprietary product formulation of 14 unique all natural ingredients, which are soy-based, is absorbed into the skin and is not visible after application. The new science is based on olfactory perception altering technology and the NOXO line of products is focused on modifying behavior, via the olfactory senses.
.
About Adoodle

Adoodle's NOXO division is focused to develop a variety of products that can modify behavior, via olfactory senses, such as smoking cessation, autism, or weight control, as examples. The company's first product to reach commercialization is called NOXO Anti-Odor, which has the ability to alter the brains ability to smell horrific odors. The odor is still there and it's not masked. The brain does not however, register its normal reaction to it. The uniquely formulated NOXO is based on advanced olfactory perception altering technology developed by Dr. V Ruth Pinney who is a director of Adoodle and who also directs the research at the company's new research center in The Woodlands, Texas.

For dealer and inquiries, please complete our online inquiry form at: www.noxoinfo.com/contact.html

NOXO product information can also be found at: www.noxoinfo.com or by calling: 1- 888-383-1743; email: support@noxoinfo.com

Investors & Media Relations:

WSMG -

Tel: 760-329-4169 or 888-383-1743

email: adde@wsmg.biz

Safe Harbor for Public Companies

Statements contained in this release that are not strictly historical are "forward-looking statements." Such forward-looking statements are sometimes identified by words such as "intends," "anticipates," "believes," "expects," and "hopes." The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include, but are not limited to, demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders. Adoodle, "The Company" currently does not file periodic filings with the Securities and Exchange Commission but will publish financials on the Adoodle website as they become available.


Richard Stevenson
Adoodle, Inc
333 E. Lancaster Ave.
Suite 317
Wynnewood, PA 19096
USA

Phone: 888-383-1743


Note: The following news is from Adoodle, Inc, and World Stock Wire, Inc. is not liable for the contents of this news.